Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham, Massachusetts.
| Revenue (TTM) | $2.86B |
| Gross Profit (TTM) | $1.56B |
| EBITDA | $840.93M |
| Operating Margin | 20.10% |
| Return on Equity | 3.22% |
| Return on Assets | 2.22% |
| Revenue/Share (TTM) | $24.51 |
| Book Value | $64.57 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 3.42 |
| EV/Revenue | 4.232 |
| EV/EBITDA | 15.78 |
| Quarterly Earnings Growth (YoY) | 12.50% |
| Quarterly Revenue Growth (YoY) | 5.90% |
| Shares Outstanding | $111.80M |
| Float | $102.66M |
| % Insiders | 0.34% |
| % Institutions | 103.07% |
Volatility is currently contracting